Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5279710
Max Phase: Preclinical
Molecular Formula: C18H16O6
Molecular Weight: 328.32
Associated Items:
ID: ALA5279710
Max Phase: Preclinical
Molecular Formula: C18H16O6
Molecular Weight: 328.32
Associated Items:
Canonical SMILES: CC1Oc2cc(O)c3c(=O)c4c(O)ccc(O)c4oc3c2C1(C)C
Standard InChI: InChI=1S/C18H16O6/c1-7-18(2,3)14-11(23-7)6-10(21)13-15(22)12-8(19)4-5-9(20)16(12)24-17(13)14/h4-7,19-21H,1-3H3
Standard InChI Key: KIUHCQDWGHJIMP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 328.32 | Molecular Weight (Monoisotopic): 328.0947 | AlogP: 3.12 | #Rotatable Bonds: 0 |
Polar Surface Area: 100.13 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.11 | CX Basic pKa: | CX LogP: 4.39 | CX LogD: 4.31 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.43 | Np Likeness Score: 2.45 |
1. Santos CMM, Freitas M, Fernandes E.. (2018) A comprehensive review on xanthone derivatives as α-glucosidase inhibitors., 157 [PMID:30282319] [10.1016/j.ejmech.2018.07.073] |
Source(1):